Homepage - CRTonline

Open

Advertisement

Previous Next

IN.PACT 014 Paclitaxel DCB Shows Comparable Effectiveness, No Safety Concerns vs. PTA Below the Knee

IN.PACT 014 Paclitaxel DCB Shows Comparable Effectiveness, No Safety Concerns vs. PTA Below the Knee https://www.crtonline.org/news-detail/in-pact-014-paclitaxel-dcb-shows-comparable-effect

Bullfrog Micro-Infusion Device Shows Robust 6-Month Outcomes in Below-the-Knee Arteries

Bullfrog Micro-Infusion Device Shows Robust 6-Month Outcomes in Below-the-Knee Arteries https://www.crtonline.org/news-detail/bullfrog-micro-infusion-device-shows-robust-6-mont

VOYAGER-PAD Analysis Shows No Mortality Increase with Paclitaxel vs. Non-Paclitaxel Devices

VOYAGER-PAD Analysis Shows No Mortality Increase with Paclitaxel vs. Non-Paclitaxel Devices https://www.crtonline.org/news-detail/voyager-pad-analysis-shows-no-mortality-increase-w

PARTNER 2: Valve-In-Valve TAVR for Failed TAVR in High-Risk Patients Shows Acceptable 5-Year Outcomes

PARTNER 2: Valve-In-Valve TAVR for Failed TAVR in High-Risk Patients Shows Acceptable 5-Year Outcomes https://www.crtonline.org/news-detail/partner-2-valve-in-valve-tavr-failed-tavr-in-high-

Cobra Stent with Short DAPT Does Not Reduce Bleeding or Show Noninferiority in Thrombosis vs. DES with standard DAPT in HBR Patients

Cobra Stent with Short DAPT Does Not Reduce Bleeding or Show Noninferiority in Thrombosis vs. DES with standard DAPT in HBR Patients https://www.crtonline.org/news-detail/cobra-stent-with-short-dapt-does-not-reduce-bleedi

Svelte DES Systems Fail to Meet Prespecified Noninferiority Criteria vs. Established DES

Svelte DES Systems Fail to Meet Prespecified Noninferiority Criteria vs. Established DES https://www.crtonline.org/news-detail/svelte-des-systems-fail-to-meet-prespecified-nonin

HOST-REDUCE-POLYTECH-ACS: Biodegradable-Polymer Stents Noninferior to Durable-Polymer Stents

HOST-REDUCE-POLYTECH-ACS: Biodegradable-Polymer Stents Noninferior to Durable-Polymer Stents https://www.crtonline.org/news-detail/host-reduce-polytech-acs-biodegradable-polymer-ste

TAVR for Failed TAVR Valves Appears Safe in High-Risk Patients at 1 Year, Study Reports

TAVR for Failed TAVR Valves Appears Safe in High-Risk Patients at 1 Year, Study Reports https://www.crtonline.org/news-detail/tavr-failed-tavr-valves-appears-safe-in-high-risk-

ACURATE neo, SAPIEN 3 Valves Show Comparable Outcomes 1 Year Post-TAVR

ACURATE neo, SAPIEN 3 Valves Show Comparable Outcomes 1 Year Post-TAVR https://www.crtonline.org/news-detail/acurate-neo-sapien-3-valves-show-comparable-outcom

MitraClip Safe, Effective in MR with Cardiogenic Shock, Registry Analysis Shows

MitraClip Safe, Effective in MR with Cardiogenic Shock, Registry Analysis Shows https://www.crtonline.org/news-detail/mitraclip-safe-effective-in-mr-with-cardiogenic-sh

Most Viewed Pages

VOYAGER-PAD Analysis Shows No Mortality Increase with Paclitaxel vs. Non-Paclitaxel Devices

Bullfrog Micro-Infusion Device Shows Robust 6-Month Outcomes in Below-the-Knee Arteries

In The News View More »

Bullfrog Micro-Infusion Device Shows Robust 6-Month Outcomes in Below-the-Knee Arteries

by
Giorgio A. Medranda, CRTonline.org

ILLUMENATE Shows Favorable Outcomes at 4 Years with Stellarex Drug-Coated Balloon

by
Giorgio A. Medranda, CRTonline.org

IN.PACT 014 Paclitaxel DCB Shows Comparable Effectiveness, No Safety Concerns vs. PTA Below the Knee

by
Jason Wermers, CRTonline.org

VOYAGER-PAD Analysis Shows No Mortality Increase with Paclitaxel vs. Non-Paclitaxel Devices

by
Jason Wermers, CRTonline.org

PARTNER 2: Valve-In-Valve TAVR for Failed TAVR in High-Risk Patients Shows Acceptable 5-Year Outcomes

by
Giorgio A. Medranda, CRTonline.org

TAVR for Failed TAVR Valves Appears Safe in High-Risk Patients at 1 Year, Study Reports

by
Giorgio A. Medranda, CRTonline.org

ACURATE neo, SAPIEN 3 Valves Show Comparable Outcomes 1 Year Post-TAVR

by
Chava Chezar-Azerrad, CRTonline.org

MitraClip Safe, Effective in MR with Cardiogenic Shock, Registry Analysis Shows

by
Charan Yerasi, CRTonline.org

Cobra Stent with Short DAPT Does Not Reduce Bleeding or Show Noninferiority in Thrombosis vs. DES with standard DAPT in HBR Patients

by
Jason Wermers, CRTonline.org
TRANSIT: Treatment of Failed TAVR With TAVR

TCT 2020 Late-Breaking Trials View More »

SCOPE I: One-year outcomes of a randomized trial comparing a self-expanding to a balloon-expandable transcatheteraortic valve

Oct 17, 2020 by Thomas Walther

Outcomes of MitraClip in Patients With Acute Mitral Regurgitation in AMI With and Without Cardiogenic Shock. IREMMI (International REgistry ...

Oct 17, 2020 by Rodrigo Estévez-Loureiro, MD, PhD

Long-term Safety of Drug-Coated Devices for Peripheral Artery Revascularization: Insights from VOYAGER-PAD

Oct 18, 2020 by Connie N. Hess

TANGO A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Oct 18, 2020 by Ehrin Armstrong, MD

Safety and Effectiveness of Drug-Coated Balloon Angioplasty versus Plain Balloon Angioplasty in the Infrapopliteal Arteries: IN.PACT BTK Ran...

Oct 18, 2020 by Antonio Micari, MD

ILLUMENATE Trial Update: 4-Year ILLUMENATE Global Stellarex DCB Data

Oct 18, 2020 by Andrew Holden

View More »

EPISODE 14 | Discussing Walter Reed
Oct 06, 2020 by Ron Waksman, Spencer B. King, III

EPISODE 13 | Discussing In-Stent Restenosis
Sep 25, 2020 by Ron Waksman, Spencer B. King, III

EPISODE 12 | Freedom is Not an Entitlement When it Comes to Healthcare
Sep 14, 2020 by Ron Waksman, Spencer B. King, III

View More »

Histopathology of COVID -19 Myocarditis - One on One with Dr. Aloke Finn
Sep 10, 2020 by Dr. Aloke Finn

COVID-19 Registry at Yale - One on One with Dr. Manan Pareek
Sep 10, 2020 by Dr. Manan Pareek

BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19 with Dr. Renato Lopes
Sep 09, 2020 by Renato D. Lopes, MD

Latest CardioTube Videos View More »

STS/ACC TVT Registry: Cerebral Embolic Protection and TAVR Outcomes

DEFINE-FLOW: An Observational Study of Deferred Lesions After FFR and CFR Assessment

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

DEFINE-PCI: One-Year Outcomes in Patients With Post-PCI Residual Ischemia

MitraBridge: Outcomes of MitraClip Treatment as Bridge Therapy to Heart Transplantation

ULTIMATE: Three-Year Outcomes After IVUS-Guided vs Angiography Guided DES Implantation

COMPARE CRUSH: A Randomized Trial of Prehospital Crushed vs Uncrushed Prasugrel in STEMI

SOLVE-TAVI: One-Year Outcomes of a Factorial Randomized Trial of Self-expandable vs Balloon-expandable TAVR and General vs Local Anesthesia

NACMI: Outcomes From the North American COVID-19 STEMI Registry

Journal Watch More »
Genetic aetiology of blood pressure relates to aortic stiffness with bi-directional causality: evidence from heritability, blood pressure polymorphism, and Mendelian randomization

Oct 12, 2020 by
M Cecelja, et al.; EHJ 2020; 41:3314-22

M Cecelja, et al.; EHJ 2020; 41:3314-22

The RECOVERY Collaborative Group. Effect of hydroxychloroquine in hospitalized patients with COVID-19

Oct 12, 2020 by
NEJM 2020 Online

NEJM 2020 Online

Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of ran

Oct 12, 2020 by
F Marsico, et al.; EHJ 2020; 41:3346-58

F Marsico, et al.; EHJ 2020; 41:3346-58

Cardiovascular Marketplace More »
Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology

Oct 14, 2020
Medtronic Announces Partnership with The Foundry to Develop Innovative Mitral Valve Repair Technology

ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP™ HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION

Sep 21, 2020
ABBOTT RECEIVES CE MARK FOR NEXT-GENERATION MITRACLIP™ HEART VALVE REPAIR DEVICE TO TREAT MITRAL REGURGITATION

Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.

Sep 21, 2020
Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.

CRT POLL

What will be the impact of shockwave on the usage of rotational and orbital atherectomy?

No impact

Decrease usage

Increase Usage

0%
No impact

100%
Decrease usage

0%
Increase Usage

Show Results

Most Downloaded
View More »

Percutaneous Coronary Intervention of Chronic Total Occlusions: When and How to Treat

Sep 21, 2020 by
Stefan P. Schumacher | Wijnand J. Stuijfzand | Maksymilian P. Opolski | Albert C. van Rossum | Alexander Nap | Paul Knaapen

Stefan P. Schumacher | Wijnand J. Stuijfzand | Maksymilian P. Opolski | Albert C. van Rossum | Alexander Nap | Paul Knaapen

Impact of the COVID-19 pandemic on acute coronary syndrome and stroke volumes in non-Western countries

Sep 21, 2020 by
Marouane Boukhris | Lorenzo Azzalini | Vitaly Baystrukov | Hatem Aloui | Evgeny Kretov | Marcelo Harada Ribeiro | Gustavo N Araujo | Marco V Wainstain | Ali Hillani | Jean Bernard Masson | Samer Mansour | Amine Nasri | Maude Sestier | Jorge Luis W Moritz | Elson Julius S Julien | Sami Souissi | Faouzi Addad

Marouane Boukhris | Lorenzo Azzalini | Vitaly Baystrukov | Hatem Aloui | Evgeny Kretov | Marcelo Harada Ribeiro | Gustavo N Araujo | Marco V Wainstain | Ali Hillani | Jean Bernard Masson | Samer Mansour | Amine Nasri | Maude Sestier | Jorge Luis W Moritz | Elson Julius S Julien | Sami Souissi | Faouzi Addad

COVID-19 (SARS-Cov-2) and the heart – An ominous association

Sep 21, 2020 by
Nauman Khalid | Yuefeng Chen | Brian C.Case | Evan Shlofmitz | Jason P. Wermers | Toby Rogers | Itsik Ben-Dor | Ron Waksman

Nauman Khalid | Yuefeng Chen | Brian C.Case | Evan Shlofmitz | Jason P. Wermers | Toby Rogers | Itsik Ben-Dor | Ron Waksman

Most Cited
View More »

Back hand approach to radial access: The snuff box approach

Sep 21, 2020 by
Rhian E. Davies | Ian C. Gilchrist

Rhian E. Davies | Ian C. Gilchrist

Distal Versus Traditional Radial Approach for Coronary Angiography

Sep 21, 2020 by
Michael Koutouzis | Eleftherios Kontopodis | Andreas Tassopoulos | Ioannis Tsiafoutis | Konstantina Katsanou | Aggeliki Rigatou | Matthaios Didagelos | Konstantinos Andreou | Efstathios Lazaris | Nikolaos Oikonomidis | Christos Maniotis | Antonios Ziakas

Michael Koutouzis | Eleftherios Kontopodis | Andreas Tassopoulos | Ioannis Tsiafoutis | Konstantina Katsanou | Aggeliki Rigatou | Matthaios Didagelos | Konstantinos Andreou | Efstathios Lazaris | Nikolaos Oikonomidis | Christos Maniotis | Antonios Ziakas

The distal left radial artery access for coronary angiography and intervention: A new era

Sep 21, 2020 by
Karim M. Al-Azizi | Amir S. Lotfi

Karim M. Al-Azizi | Amir S. Lotfi

Just Accepted
View More »

Safety and Efficacy of Apixaban, Rivaroxaban, and Warfarin in End-Stage Renal Disease with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Oct 03, 2020
Safety and Efficacy of Apixaban, Rivaroxaban, and Warfarin in End-Stage Renal Disease with Atrial Fibrillation: A Systematic Review and Meta-Analysis

Cases of Early, Aggressive In-Stent Restenosis in Left Main Double Kissing (DK) Crush Technique and Treatment Options

Oct 03, 2020
Cases of Early, Aggressive In-Stent Restenosis in Left Main Double Kissing (DK) Crush Technique and Treatment Options

Facilitated Intravascular Ultrasound-Guided Balloon-Assisted Re-entry Technique for Complex Lower Extremity Chronic Total Occlusions: The FIBRE Technique

Oct 03, 2020
Facilitated Intravascular Ultrasound-Guided Balloon-Assisted Re-entry Technique for Complex Lower Extremity Chronic Total Occlusions: The FIBRE Technique

Treating Ventricular Tachycardia with Mechanical Valves

Video Presentations View More »

Impella with Distal LMCA Bifurcation PCI

Oct 14, 2020

HeartFlow FFRct

Oct 09, 2020

First-in-Human Transcatheter Tricuspid Valve Repair 30-Day Follow-Up Experience With the Mistral Device

Oct 01, 2020

Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing

Sep 22, 2020

Saranas Bleed Monitoring System During Endovascular Procedures

Sep 16, 2020

Revascularization Deferral of Nonculprit Stenoses on the Basis of FFR 1-Year Outcomes of 8,579 Patients

Sep 16, 2020

ISCTR Online Course
CRTonline on Facebook

CRT Meeting

CRTonline on Twitter

Tweets by CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

* Required
* First Name:
* Last Name:
Member ID:
* Phone Number:
* Email:
* Enter code:

* Message:

IN.PACT 014 Paclitaxel DCB Shows Comparable Effectiveness, No Safety Concerns vs. PTA Below the Knee

IN.PACT 014 Paclitaxel DCB Shows Comparable Effectiveness, No Safety Concerns vs. PTA Below the Knee https://www.crtonline.org/news-detail/in-pact-014-paclitaxel-dcb-shows-comparable-effect

Bullfrog Micro-Infusion Device Shows Robust 6-Month Outcomes in Below-the-Knee Arteries

Bullfrog Micro-Infusion Device Shows Robust 6-Month Outcomes in Below-the-Knee Arteries https://www.crtonline.org/news-detail/bullfrog-micro-infusion-device-shows-robust-6-mont

VOYAGER-PAD Analysis Shows No Mortality Increase with Paclitaxel vs. Non-Paclitaxel Devices

VOYAGER-PAD Analysis Shows No Mortality Increase with Paclitaxel vs. Non-Paclitaxel Devices https://www.crtonline.org/news-detail/voyager-pad-analysis-shows-no-mortality-increase-w

PARTNER 2: Valve-In-Valve TAVR for Failed TAVR in High-Risk Patients Shows Acceptable 5-Year Outcomes

PARTNER 2: Valve-In-Valve TAVR for Failed TAVR in High-Risk Patients Shows Acceptable 5-Year Outcomes https://www.crtonline.org/news-detail/partner-2-valve-in-valve-tavr-failed-tavr-in-high-

Cobra Stent with Short DAPT Does Not Reduce Bleeding or Show Noninferiority in Thrombosis vs. DES with standard DAPT in HBR Patients

Cobra Stent with Short DAPT Does Not Reduce Bleeding or Show Noninferiority in Thrombosis vs. DES with standard DAPT in HBR Patients https://www.crtonline.org/news-detail/cobra-stent-with-short-dapt-does-not-reduce-bleedi

Svelte DES Systems Fail to Meet Prespecified Noninferiority Criteria vs. Established DES

Svelte DES Systems Fail to Meet Prespecified Noninferiority Criteria vs. Established DES https://www.crtonline.org/news-detail/svelte-des-systems-fail-to-meet-prespecified-nonin

HOST-REDUCE-POLYTECH-ACS: Biodegradable-Polymer Stents Noninferior to Durable-Polymer Stents

HOST-REDUCE-POLYTECH-ACS: Biodegradable-Polymer Stents Noninferior to Durable-Polymer Stents https://www.crtonline.org/news-detail/host-reduce-polytech-acs-biodegradable-polymer-ste

TAVR for Failed TAVR Valves Appears Safe in High-Risk Patients at 1 Year, Study Reports

TAVR for Failed TAVR Valves Appears Safe in High-Risk Patients at 1 Year, Study Reports https://www.crtonline.org/news-detail/tavr-failed-tavr-valves-appears-safe-in-high-risk-

ACURATE neo, SAPIEN 3 Valves Show Comparable Outcomes 1 Year Post-TAVR

ACURATE neo, SAPIEN 3 Valves Show Comparable Outcomes 1 Year Post-TAVR https://www.crtonline.org/news-detail/acurate-neo-sapien-3-valves-show-comparable-outcom

MitraClip Safe, Effective in MR with Cardiogenic Shock, Registry Analysis Shows

MitraClip Safe, Effective in MR with Cardiogenic Shock, Registry Analysis Shows https://www.crtonline.org/news-detail/mitraclip-safe-effective-in-mr-with-cardiogenic-sh

Most Viewed Pages

In The News View More »

TCT 2020 Late-Breaking Trials View More »

Latest CardioTube Videos View More »

Journal Watch More »

Cardiovascular Marketplace More »

CRT POLL

Most Downloaded

Most Cited

Just Accepted

Video Presentations View More »

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected

Thank you